
Revoglip-M 1000 Tablet SR
Marketer
Zuventus Healthcare Ltd
Salt Composition
Metformin (1000mg) + Teneligliptin (20mg)
Overview Revoglip-M 1000 Tablet SR
Glycipan-XR 1000mg extended-release tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney disease and vision loss, and may lessen the risk of cardiovascular events such as heart attack or stroke. Glycipan-XR 1000mg may be used as a monotherapy or in conjunction with other antidiabetic agents. Optimal results require adherence to a prescribed diet and regular physical activity. Dosage is personalized based on individual health status, blood sugar readings, and other concurrent medications. Taking the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time each day, maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Effective blood sugar control helps prevent future complications. Maintaining the recommended dietary and exercise plan is crucial for successful diabetes management; lifestyle choices are integral to overall control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, and headache. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylurea medications; patients should be educated on its recognition and management. This medication isn't appropriate for all patients. Prior to initiating treatment, inform your physician about any pre-existing kidney, liver, heart, or pancreatic conditions, as well as significant alcohol consumption. Pregnant or breastfeeding individuals require medical consultation before use. Interactions with other medications are possible; therefore, disclose all current medications to your doctor to ensure safety. Alcohol should be limited due to its potential to lower blood glucose. Your doctor will monitor kidney function and blood glucose levels throughout the treatment period.
Primary Ingredients of Revoglip-M 1000 Tablet SR
No text provided to rephrase.
Uses of Revoglip-M 1000 Tablet SR
Managing type 2 diabetes
Major Benefits of Revoglip-M 1000 Tablet SR:
Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Consume Revoglip-M 1000 Tablet SR with a meal.
Common Side effects of Revoglip-M 1000 Tablet SR:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Revoglip-M 1000 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Revoglip-M 1000 Tablet SR with a meal.
How Revoglip-M 1000 Tablet SR works:
Extended-release Revoglip-M 1000 tablets contain a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Revoglip-M 1000 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Revoglip-M 1000 SR tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Revoglip-M 1000mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Revoglip-M 1000 Tablet SR on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when prescribing Revoglip-M 1000 SR tablets to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Revoglip-M 1000 SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverUNSAFE
Use of Revoglip-M 1000 SR tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.
What if you forget to take Revoglip-M 1000 Tablet SR :
Should you forget to take a Revoglip-M 1000 Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Revoglip-M 1000 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
